Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of infliximab effects on endothelial function in psoriasis
jRCTs031180367Completed
- Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Start
- Feb 2018
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of infliximab in plaque psoriasis, psoriatic arthritis (PsA), pustular psoriasis and 1 more, sponsored by Mitsubishi Tanabe Pharma Corporation. Started Feb 2018; status: completed.
02
Drugs
infliximab
03
Conditions
plaque psoriasispsoriatic arthritis (PsA)pustular psoriasiserythrodermic psoriasis (EP)
Beyond the preview
Go deeper on jRCTs031180367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180367.